Related references
Note: Only part of the references are listed.Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
Yi-Zhou Jiang et al.
CANCER CELL (2019)
Premature mitotic entry induced by ATR inhibition potentiates olaparib inhibition-mediated genomic instability, inflammatory signaling, and cytotoxicity in BRCA2-deficient cancer cells
Pepijn M. Schoonen et al.
MOLECULAR ONCOLOGY (2019)
Unresolved recombination intermediates lead to ultra-fine anaphase bridges, chromosome breaks and aberrations
Ying Wai Chan et al.
NATURE CELL BIOLOGY (2018)
Prognostic Values of CCNE1 Amplification and Overexpression in Cancer Patients: A Systematic Review and Meta-analysis
Haiyue Zhao et al.
JOURNAL OF CANCER (2018)
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Xian Chen et al.
CLINICAL CANCER RESEARCH (2018)
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis
Ayse Ayhan et al.
MODERN PATHOLOGY (2017)
Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells
Pepijn M. Schoonen et al.
NATURE COMMUNICATIONS (2017)
Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway
C. Peng et al.
ONCOGENE (2016)
Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months
Suzanne Leijen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
A Genome-wide CRISPR Screen Identifies CDC25A as a Determinant of Sensitivity to ATR Inhibitors
Sergio Ruiz et al.
MOLECULAR CELL (2016)
Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies
Bjorn Bakker et al.
GENOME BIOLOGY (2016)
Cyclin E Deregulation Promotes Loss of Specific Genomic Regions
Leonardo K. Teixeira et al.
CURRENT BIOLOGY (2015)
Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma
Oumou Goundiam et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Replication stress activates DNA repair synthesis in mitosis
Sheroy Minocherhomji et al.
NATURE (2015)
Sequential cancer mutations in cultured human intestinal stem cells
Jarno Drost et al.
NATURE (2015)
A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity
Anne Margriet Heijink et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Oncogenes create a unique landscape of fragile sites
Karin Miron et al.
NATURE COMMUNICATIONS (2015)
ATR inhibition preferentially targets homologous recombination-deficient tumor cells
M. Krajewska et al.
ONCOGENE (2015)
Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia - The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms
Annette K. Brenner et al.
MOLECULES (2014)
Causes and consequences of replication stress
Michelle K. Zeman et al.
NATURE CELL BIOLOGY (2014)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress
R. M. Jones et al.
ONCOGENE (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Functional characterization of the 19q12 amplicon in grade III breast cancers
Rachael Natrajan et al.
BREAST CANCER RESEARCH (2012)
Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development
Assaf C. Bester et al.
CELL (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
Matilde Murga et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
Luis I. Toledo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
A human cancer-predisposing polymorphism in Cdc25A is embryonic lethal in the mouse and promotes ASK-1 mediated apoptosis
El Mustapha Bahassi et al.
CELL DIVISION (2011)
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
M. Gerlinger et al.
BRITISH JOURNAL OF CANCER (2010)
MK-1775, a small molecule Wee1 inhibitor, enhances antitumor efficacy of various DNA-damaging agents, including 5-fluorouracil
Hiroshi Hirai et al.
CANCER BIOLOGY & THERAPY (2010)
Genomic instability - an evolving hallmark of cancer
Simona Negrini et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
A Mitotic Phosphorylation Feedback Network Connects Cdk1, Plk1, 53BP1, and Chk2 to Inactivate the G2/M DNA Damage Checkpoint
Marcel A. T. M. van Vugt et al.
PLOS BIOLOGY (2010)
Cyclin A overexpression induces chromosomal double-strand breaks in mammalian cells
Shoji Tane et al.
CELL CYCLE (2009)
Single-vector inducible lentiviral RNAi system for oncology target validation
Dmitri Wiederschain et al.
CELL CYCLE (2009)
Replication stress induces sister-chromatid bridging at fragile site loci in mitosis
Kok Lung Chan et al.
NATURE CELL BIOLOGY (2009)
Deregulated CDC25A expression promotes mammary tumorigenesis with genomic instability
Dipankar Ray et al.
CANCER RESEARCH (2007)
Diffuse large B-cell lymphoma with overexpression of cyclin E substantiates poor standard treatment response and inferior outcome
A Tzankov et al.
CLINICAL CANCER RESEARCH (2006)
A mouse model for cyclin E-dependent genetic instability and tumorigenesis
KR Loeb et al.
CANCER CELL (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Cyclin E overexpression and amplification in human tumours
P Schraml et al.
JOURNAL OF PATHOLOGY (2003)
p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation
AC Minella et al.
CURRENT BIOLOGY (2002)
Evidence for sequential action of cdc7 and cdk2 protein kinases during initiation of DNA replication in Xenopus egg extracts
JC Walter
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
